3-甲氧基-5-甲基苯甲酸甲酯 | 108593-44-8

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-甲氧基-5-甲基苯甲酸甲酯
• 中文别名: 3-甲氧基-5-甲基-苯甲酸甲酯
• 英文名称: methyl 3-methoxy-5-methylbenzoate
• CAS: 108593-44-8
• 化学式: C₁₀H₁₂O₃
• mdl: MFCD09833214
• 分子量: 180.203
• InChiKey: QPZNMWJDXUEMOJ-UHFFFAOYSA-N

物化性质

• 沸点：
  270.8±20.0 °C(Predicted)
• 密度：
  1.075±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2918990090
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302
• 储存条件：
  存于室温下，密封保存，并确保环境干燥。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl 5-methoxy-3-methylbenzoate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 5-methoxy-3-methylbenzoate
CAS number: 108593-44-8

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H12O3
Molecular weight: 180.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-甲氧基-5-甲基苯甲酸甲酯 在 钯 manganese(IV) oxide 、 lithium aluminium tetrahydride 、 正丁基锂 、 ammonium cerium(IV) nitrate 、 氰化钠 、 氢气 、 碘 、 potassium carbonate 、 溶剂黄146 、 pyridinium chlorochromate 、 锌 作用下， 以 水 、 丙酮 、 乙腈 为溶剂， 生成 defucogilvocarcin M
  参考文献：
  名称：

  8-甲基苯并萘并吡喃酮抗生素，gilvocarcin M，virenomycin M和albacarcin M的糖苷配基的全合成

  摘要：

  描述了8-甲基苯并萘并吡喃酮抗生素的糖苷配基5a的短的，会聚的合成，其将Suzuki联芳基偶联用作关键步骤。

  DOI：

  10.1016/s0040-4039(00)86100-6
• 作为产物：
  描述：

  3-羟基-5-甲基苯甲酸 在 硫酸 作用下， 生成 3-甲氧基-5-甲基苯甲酸甲酯
  参考文献：
  名称：

  Meldrum, Journal of the Chemical Society, 1911, vol. 99, p. 1718

  摘要：

  DOI：

文献信息

• [EN] THERAPEUTIC COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS THÉRAPEUTIQUES ET LEURS UTILISATIONS
  申请人：GENENTECH INC

  公开号：WO2016123391A1

  公开（公告）日：2016-08-04

  The present invention relates to compounds of formula (I): and to salts thereof, wherein R1-R6 have any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of TAF1. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various TAF1-mediated disorders.

  本发明涉及式(I)的化合物及其盐，其中R1-R6具有规范中定义的任何值，以及其组合物和用途。这些化合物可用作TAF1的抑制剂。还包括包含式(I)的化合物或其药学上可接受的盐的药物组合物，以及在治疗各种TAF1介导的疾病中使用这些化合物和盐的方法。
• [EN] THIAZOLE AND OXAZOLE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASE À BASE DE THIAZOLE ET D'OXAZOLE
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2009032667A1

  公开（公告）日：2009-03-12

  The present invention provides thiazole and oxazole compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.

  本发明提供噻唑和氧唑化合物，含有这些化合物的组合物，以及用作药用剂的制备方法和使用方法。
• Design, Synthesis, and In Vitro Cytotoxic Activity of Certain 2-[3-Phenyl-4-(pyrimidin-4-yl)-1H-pyrazol1-yl]acetamide Derivatives
  作者：M. M. Al-Sanea、D. G. T. Parambi、M. E. Shaker、H. A. M. Elsherif、H. A. H. Elshemy、R. B. Bakr、T. I. M. Al-Warhi、M. Gamal、M. A. Abdelgawad

  DOI：10.1134/s1070428020030239

  日期：2020.3

  AbstractWith a view to finding new anticancer agents, different aryloxy groups were attached to C2 of the pyrimidine ring in 2-[3-phenyl-4-(pyrimidin-4-yl)-1H-pyrazol-1-yl]acetamide in five steps using methyl 3-methoxy-5-methylbenzoate as the key intermediate product. The anticancer activity of the synthesized compounds was tested on 60 cancer cell lines at 10 µM. One compound showed an appreciable

  摘要为了寻找新的抗癌药，在2- [3-苯基-4-（嘧啶-4-基）-1H-吡唑-1-基]乙酰胺中的嘧啶环的C 2上连接了不同的芳氧基。使用3-甲氧基-5-甲基苯甲酸甲酯作为关键中间产物的五个步骤。在10 µM的60种癌细胞系上测试了合成化合物的抗癌活性。一种化合物对八种癌细胞系（HOP-92，NCI-H226、79SNB-75，A498，SN12C，UO-31，T-47D和MDA-MB-468）表现出明显的癌细胞生长抑制作用（约20％） ）。
• ＲＯＳ 카이네이즈 저해활성을 갖는 2,4,6-삼치환된 피리미딘 화합물
  申请人：KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY 한국과학기술연구원(319980077518) BRN ▼209-82-03522

  公开号：KR101556317B1

  公开（公告）日：2015-10-01

  본 발명은 신규 2,4,6-삼치환된 피리미딘 화합물과 약제학적으로 허용 가능한 이의 염, 이 화합물의 제조방법, 그리고 이 화합물을 항암제로 사용하는 의약용도에 관한 것이다. 본 발명에 따른 신규 화합물들은 ROS 카이네이즈 엔자임에 대하여 매우 우수한 활성을 가지고 있으므로 뇌암, CNS 관련 암, 수막종 (meningiomas)과 역형성별 세포종 (astrocytomas), 다형성 교모세포종 (glioblastoma multiforme), 비소세포성 폐암 (NSCLC) 등의 질환을 치료 및 예방하는 항암제로 유용하다.

  This is the Chinese translation of the text you provided: 该发明涉及新型2,4,6-三取代嘧啶化合物及其药学上可接受的盐，该化合物的制备方法，以及将该化合物用作抗癌药物的药用用途。根据本发明，这些新型化合物对ROS激酶酶表现出非常优异的活性，因此对治疗和预防脑癌、与中枢神经系统相关的癌症、脑膜瘤（meningiomas）和星形胶质细胞瘤（astrocytomas）、多形性胶质母细胞瘤（glioblastoma multiforme）、非小细胞肺癌（NSCLC）等疾病具有用处。
• PYRAZOLE COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST ROS KINASE
  申请人：LEE So Ha

  公开号：US20110015395A1

  公开（公告）日：2011-01-20

  Disclosed herein are novel pyrazole compounds, pharmaceutically acceptable salts thereof, a method for preparing the same, and uses thereof as anticancer agents.

  本文披露了新型吡唑化合物，其药用盐，其制备方法，以及作为抗癌剂的用途。